Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.905 USD | +0.87% | +4.29% | +16.80% |
09/05 | Whitefort Capital Management Engages with Arbutus Biopharma | CI |
02/05 | Transcript : Arbutus Biopharma Corporation, Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.80% | 544M | |
-2.35% | 89.08B | |
+3.55% | 40.9B | |
-13.39% | 32.25B | |
+53.99% | 25.14B | |
-15.83% | 15.39B | |
-7.33% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+6.82% | 9.03B |
- Stock Market
- Equities
- ABUS Stock
- News Arbutus Biopharma Corporation
- HC Wainwright Adjusts Arbutus Biopharma's Price Target to $8.50 From $8, Maintains Buy Rating